The Latest Breaking News from diabetes

The researchers recommend adopting time-restricted eating as an alternative dietary strategy for diabetic patients were individualized dietary plans do not work or cannot be accessed.

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.

Diagnosing diabetes before 40 quadrupled the risk of early death and later onset was linked to a one-and-a-half times higher risk of death compared with the general population without the condition.

Dexcom stock closed in the red on Friday after the diabetes devices player beat third-quarter expectations and kept its outlook.

Type 2 diabetes affects 1.2 million Australians and accounts for 85-90% of all diabetes cases. This chronic condition is characterised by high blood glucose (sugar) levels, which carry serious health risks. Complications include heart disease, kidney failure and vision problems.

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing Alzheimer’s disease.

Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of developing the disease, the study found

The study reveals that even a single bout of exercise could help reduce type 2 diabetes risk factors, with benefits notable by the next day.

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.

A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 diabetes.

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…